NovoCure's Other Working Capital Changes fell 5810.02% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.9 million, marking a year-over-year increase of 4468.33%. This contributed to the annual value of -$6.4 million for FY2024, which is 3497.6% up from last year.
Per NovoCure's latest filing, its Other Working Capital Changes stood at -$2.4 million for Q3 2025, which was down 5810.02% from $920000.0 recorded in Q2 2025.
In the past 5 years, NovoCure's Other Working Capital Changes ranged from a high of $920000.0 in Q2 2025 and a low of -$4.4 million during Q1 2021
Moreover, its 5-year median value for Other Working Capital Changes was -$1.8 million (2023), whereas its average is -$2.0 million.
As far as peak fluctuations go, NovoCure's Other Working Capital Changes crashed by 185288.89% in 2021, and later soared by 15030.07% in 2025.
Over the past 5 years, NovoCure's Other Working Capital Changes (Quarter) stood at -$2.2 million in 2021, then increased by 24.89% to -$1.7 million in 2022, then dropped by 10.67% to -$1.8 million in 2023, then surged by 33.46% to -$1.2 million in 2024, then tumbled by 97.72% to -$2.4 million in 2025.
Its Other Working Capital Changes was -$2.4 million in Q3 2025, compared to $920000.0 in Q2 2025 and -$1.1 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value